SS
CALA

Steve Schonfeld’s Calithera Biosciences, Inc CALA Stock Holding History

Steve Schonfeld’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,741
Closed -$214K – 1323
2019
Q2 		$214K Buy
+2,741
New +$311K 0.01% 874
2017
Q3 		– Sell
-3,750
Closed -$1.11M – 825
2017
Q2 		$1.11M Sell
3,750
-17,320
-82% -$4.63M 0.11% 259
2017
Q1 		$4.87M Buy
+21,070
New +$3.64M 0.49% 47

Other funds holding CALA

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Steve Schonfeld's CALA Position: Q3 2019 in Review

Steve Schonfeld sold out of Calithera Biosciences, Inc (CALA) in Q3 2019, closing a stake of 2,741 shares — an estimated $214K sold.

Steve Schonfeld first reported a position in CALA in Q1 2017 and held it in 3 quarters. The position peaked at $4.87M in Q1 2017. 85 funds tracked by Wall St. Rank hold CALA as of Q3 2019.

  • Steve Schonfeld reported no remaining Calithera Biosciences, Inc position as of Q3 2019 after selling out during the quarter.
  • Steve Schonfeld sold 2,741 Calithera Biosciences, Inc shares in Q3 2019, an estimated $214K.
  • Steve Schonfeld first reported a position in Calithera Biosciences, Inc in Q1 2017 and held it in 3 quarters.
  • Steve Schonfeld's Calithera Biosciences, Inc position peaked at $4.87M in Q1 2017.
  • 85 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2019.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.